• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

ER docs can pick your nose

Bioengineer.org by Bioengineer.org
January 26, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: American College of Emergency Physicians

WASHINGTON — The range of options for medicating emergency patients intranasally has greatly expanded in recent years and can even be preferable for certain patients, including children, according to the results of a paper published online last Thursday in Annals of Emergency Medicine ("When to Pick the Nose: Out-of-Hospital and Emergency Department Intranasal Administration of Medications").

"For patients who are combative or having seizures, intranasal administration of certain medications can be really helpful," said lead study author Megan Rech, PharmD, MS, BCPS, BCCP of Loyola University Medical Center in Maywood, Ill. "These formulations can be especially useful for children, as they are not as painful and frightening as using intravenous or intramuscular routes. This route can also be an effective option for treating opioid overdoses."

Common medications that can be administered via an atomizer that sprays the surface of the nasal cavity include midazolam, fentanyl, naloxone, ketamine and dexmedetomidine.

Midazolam, administered intranasally, can tranquilize and sedate children who are undergoing numerous emergency procedures. It can also be used to treat seizures in both adults and children. Fentanyl, a synthetic opioid, can be administered to adults and children intranasally for pain relief. Naloxone administered intranasally can be a first-line therapy in suspected opioid overdoses where there is no intravenous access because it can be simply and rapidly administered by lay persons and out-of-hospital personnel. Ketamine, an analgesic, can be administered intranasally for adults and children who have orthopedic injuries or who are undergoing nasogastric tube placement. Intranasal dexmedetomidine works well to sedate and relieve pain for surgical and dental procedures in children.

"Administering medications intranasally in the pre-hospital or emergency setting can be easy, fast and non-invasive," said Dr. Rech. "It is a welcome option for emergency physicians treating a wide variety of patients, sometimes in difficult situations."

###

Annals of Emergency Medicine is the peer-reviewed scientific journal for the American College of Emergency Physicians, the national medical society representing emergency medicine. ACEP is committed to advancing emergency care through continuing education, research, and public education. Headquartered in Dallas, Texas, ACEP has 53 chapters representing each state, as well as Puerto Rico and the District of Columbia. A Government Services Chapter represents emergency physicians employed by military branches and other government agencies. For more information, visit http://www.acep.org.

Media Contact

Julie Lloyd
[email protected]
202-370-9292
@emergencydocs

http://www.acep.org

Share12Tweet7Share2ShareShareShare1

Related Posts

Childhood Trauma, HIV, and Women’s Mental Health Insights

September 7, 2025

9-Fluorenone Sulfonamides: Dual Inhibitors of SARS-CoV-2 Proteases

September 7, 2025

Shikonin Blocks EMT in Glioblastoma via p53 Activation

September 7, 2025

Home Pumping Influences Bacterial Load in Human Milk

September 7, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    55 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Childhood Trauma, HIV, and Women’s Mental Health Insights

9-Fluorenone Sulfonamides: Dual Inhibitors of SARS-CoV-2 Proteases

Shikonin Blocks EMT in Glioblastoma via p53 Activation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.